George Simeon
George Simeon is a board director and former Chairman and CEO of Curevo Vaccine, where he led the company from formation through clinical development, raised over $200 million in venture financing, and oversaw its acquisition by Eli Lilly. He previously founded HealthLink Global and served as CEO at Black Kactus LLC. His executive leadership roles have included positions at Johnson & Johnson, Novartis, SK Telecom, GHX Europe, and Forth Photonics Ltd.
Curevo Raises $110M Series B to Advance Shingles Vaccine Amid GSK Competition, Adds Former GSK and Moderna Execs to Board
Seattle biotech startup Curevo raised $110 million in a Series B round to advance Phase 2 trials of its shingles vaccine amezosvatein, competing with GlaxoSmithKline's Shingrix. The company added biotech veterans, including former GSK and Moderna executives, to its board to support development.
Curevo Vaccine Raises $110M Series B Led by Medicxi to Advance Amezosvatein Shingles Vaccine; Moncef Slaoui Named Board Chair
Curevo Vaccine raised $110 million in a Series B led by Medicxi to advance its shingles vaccine amezosvatein, funding a Phase 2 extension of 640 participants including adults over 70 to finalize dose selection before Phase 3; Moncef Slaoui will join as Board Chair.
Seattle Startup Curevo Raises $26M to Develop Shingles Vaccine Rivaling GSK’s $2.3B Shingrix
Seattle vaccine startup Curevo raised $26 million to advance its shingles vaccine CRV-101, competing against GSK's $2.3 billion Shingrix vaccine with a potentially safer, equally effective alternative. Curevo completed enrollment in a Phase 2b trial comparing CRV-101 to Shingrix, with results expected in early 2023.
See all 4 stories, episodes and videos about George Simeon.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
See all 9-
Curevo Executive Officer, Director 2022, Former Chairman & Chief Executive Officer 2019 · past -
Black Kactus LLC CEO 2018–2020 · past
-
SK Telecom Healthcare Strategy Team 2014–2018 · past
Education
-
Università Bocconi Master of Philosophy - MPhil, Strategy & Technology Management · 2004–2007
-
INSEAD MBA · 1998–1999
-
Yale School of Public Health Master of Public Health - MPH, Epidemiology, Health Economics · 1992–1994
-
University of Ottawa B.Soc.Sc, Economics · 1988–1992